Status:
COMPLETED
Association of Androgenetic Alopecia and Severity of Coronavirus Disease 2019 (COVID-19).
Lead Sponsor:
Syeda Mahanum Ali
Conditions:
Androgenetic Alopecia
Coronavirus Disease 2019
Eligibility:
All Genders
20-100 years
Brief Summary
Coronavirus disease 2019 (COVID-19) can cause variable symptoms ranging from mild common cold-like symptoms to severe life threatening pneumonia. Recent studies show severe outcomes of COVID-19 patien...
Detailed Description
INTRODUCTION: An outbreak of Corona virus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-coV-2) occurred in Wuhan city, Hubei province, China in December 2019....
Eligibility Criteria
Inclusion
- Hospitalized patients of diagnosed covid-19 age \> 20years
- with or without androgenetic alopecia
- with or without comorbidities
- irrespective of disease duration -
Exclusion
- none
Key Trial Info
Start Date :
December 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 31 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04898166
Start Date
December 1 2020
End Date
March 31 2021
Last Update
October 26 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jinnah postgraduate medical center
Karachi, Sindh, Pakistan, 75510